Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Not Confirmed
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
01-02 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Industry Trade Show
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
01-02 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
12 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-pharma-america-announces-that-nuvisertib-tp-3654-has-received-fda-fast-track-designation-for-the-treatment-of-myelofibrosis-302480390.html
14 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-pharma-america-enters-into-a-cooperative-research-and-development-agreement-with-the-national-cancer-institute-to-advance-clinical-understanding-of-enzomenib-302426994.html
30 Jan 2025
// BUSINESSWIRE
20 Jan 2025
// BUSINESSWIRE
07 Aug 2024
// BUSINESSWIRE
15 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-pharma-announces-that-dsp-5336-has-received-fda-fast-track-designation-for-the-treatment-of-relapsed-or-refractory-acute-myeloid-leukemia-302196812.html
Inspections and registrations
ABOUT THIS PAGE
Sumitomo Pharma is a supplier offers 16 products (APIs, Excipients or Intermediates).
Find a price of Lurasidone Hydrochloride bulk with DMF offered by Sumitomo Pharma
Find a price of Zonisamide bulk with DMF offered by Sumitomo Pharma
Find a price of Amrubicin bulk offered by Sumitomo Pharma
Find a price of Droxidopa bulk offered by Sumitomo Pharma
Find a price of Enoxacin bulk offered by Sumitomo Pharma
Find a price of Meropenem bulk offered by Sumitomo Pharma
Find a price of Ranirestat bulk offered by Sumitomo Pharma
Find a price of Rimacalib bulk offered by Sumitomo Pharma
Find a price of Sm-216601 bulk offered by Sumitomo Pharma
Find a price of Smp 797 bulk offered by Sumitomo Pharma
Find a price of Sparfloxacin bulk offered by Sumitomo Pharma
Find a price of SMP-028 bulk offered by Sumitomo Pharma
Find a price of SMP-986 bulk offered by Sumitomo Pharma
Find a price of Blonanserin bulk offered by Sumitomo Pharma
Find a price of Mosapride Citrate bulk offered by Sumitomo Pharma
Find a price of Sodium Hyaluronate bulk offered by Sumitomo Pharma